Researchers are looking into its applications beyond weight loss, where it could potentially serve as a therapeutic agent for obesity and related metabolic disorders
The clustering between specific biological and clinical features has been postulated to identify a theoretical dimension labelled immuno-metabolic depression (IMD) [2] (aligning with the Research Domain Criteria (RDoC) framework [52]
[DOI] [PubMed] [Google Scholar] 24.Onofrj M., Ciccocioppo F., Varanese S., di Muzio A., Calvani M., Chiechio S., Osio M., Thomas A
Lifestyle causes of male infertility
In glucocorticoid-induced atrophy models (dexamethasone 1mg/kg/day for 7 days in rodents), IGF-1 LR3 (0.5-1mg/kg/day) reduced Atrogin-1 by 42-52% and preserved myofibre cross-sectional area (H&E gastrocnemius CSA 18% vs dexamethasone alone vs 6% with IGF-1 LR3 co-treatment)
Geographic differences in digoxin inactivation, a metabolic activity of the human anaerobic gut flora